{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:43:02Z","timestamp":1785307382109,"version":"3.55.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cld.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T07:10:47Z","timestamp":1662880247000},"page":"555-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Contemporary Epidemiology of Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"26","author":[{"given":"Francesca","family":"Colapietro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bertazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10266","key":"10.1016\/j.cld.2022.06.001_bib1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cld.2022.06.001_bib2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2022.06.001_bib3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2022.06.001_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000440705","article-title":"Worldwide incidence of autoimmune liver disease","volume":"33","author":"Jepsen","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.cld.2022.06.001_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2013.06.015","article-title":"The limitations and hidden gems of the epidemiology of primary biliary cirrhosis","volume":"46","author":"Podda","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.cld.2022.06.001_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis","volume":"36","author":"Lv","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00281-018-0715-8","article-title":"Sex-related factors in autoimmune liver diseases","volume":"41","author":"Schwinge","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cld.2022.06.001_bib10","doi-asserted-by":"crossref","first-page":"25906","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.cld.2022.06.001_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/hepr.13342","article-title":"Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan","volume":"49","author":"Tanaka","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2022.06.001_bib12","doi-asserted-by":"crossref","first-page":"9151525","DOI":"10.1155\/2021\/9151525","article-title":"The epidemiology of primary biliary cholangitis in European countries: a systematic review and meta-analysis","volume":"2021","author":"Gazda","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib14","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1053\/j.gastro.2021.02.061","article-title":"X\u00a0chromosome contribution to the genetic Architecture of primary biliary cholangitis","volume":"160","author":"Asselta","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwt308","article-title":"No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England","volume":"179","author":"McNally","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.31776","article-title":"Male sex is associated with higher rates of liver-related mortality in primary biliary cholangitis and cirrhosis","volume":"74","author":"John","year":"2021","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2022.06.001_bib18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.14309\/ajg.0000000000001280","article-title":"Ursodeoxycholic acid response is associated with reduced mortality in primary biliary cholangitis with Compensated cirrhosis","volume":"116","author":"John","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib19","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29717","article-title":"Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history","volume":"67","author":"Murillo Perez","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib21","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1111\/liv.12479","article-title":"Geoepidemiology and space-time analysis of Primary biliary cirrhosis in Crete, Greece","volume":"34","author":"Koulentaki","year":"2014","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib22","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MEG.0b013e328353753d","article-title":"The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study","volume":"24","author":"Baldursdottir","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.29675","article-title":"Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis","volume":"68","author":"Ornolfsson","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0034-1383730","article-title":"The new epidemiology of primary biliary cirrhosis","volume":"34","author":"Griffiths","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"12","key":"10.1016\/j.cld.2022.06.001_bib25","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.cgh.2021.01.029","article-title":"The epidemiology of UK autoimmune liver disease varies with geographic latitude","volume":"19","author":"Webb","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.42.1.120","article-title":"The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences","volume":"42","author":"Kingham","year":"1998","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.510300213","article-title":"Primary biliary cirrhosis once rare, now common in the United Kingdom?","volume":"30","author":"James","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1532-0464(02)00526-9","article-title":"The epidemiology of liver disease in Tayside database: a population-based record-linkage study","volume":"35","author":"Steinke","year":"2002","journal-title":"J\u00a0Biomed Inform"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/00365528509089711","article-title":"Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden","volume":"20","author":"Lofgren","year":"1985","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.1840110317","article-title":"Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden","volume":"11","author":"Danielsson","year":"1990","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib31","doi-asserted-by":"crossref","first-page":"11525","DOI":"10.1038\/s41598-019-47890-2","article-title":"Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort","volume":"9","author":"Marschall","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.cld.2022.06.001_bib32","first-page":"641","article-title":"Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment","volume":"110","author":"Pares","year":"2018","journal-title":"Rev Esp Enferm Dig"},{"issue":"8","key":"10.1016\/j.cld.2022.06.001_bib33","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","article-title":"Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.06.001_bib34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cld.2008.02.001","article-title":"Recent advances in the epidemiology of primary biliary cirrhosis","volume":"12","author":"Gross","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"11","key":"10.1016\/j.cld.2022.06.001_bib37","first-page":"717","article-title":"The epidemiology of primary biliary cirrhosis in southern Israel","volume":"7","author":"Delgado","year":"2005","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"10.1016\/j.cld.2022.06.001_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s12072-019-09984-x","article-title":"Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis","volume":"13","author":"Zeng","year":"2019","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib39","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s12072-011-9329-0","article-title":"Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based study","volume":"6","author":"Ngu","year":"2012","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3350\/cmh.2017.0066","article-title":"Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea","volume":"24","author":"Jeong","year":"2018","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cld.2022.06.001_bib41","first-page":"1","article-title":"Antimitochondrial antibodies: from Bench to Bedside","volume":"Sep 29","author":"Colapietro","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/liv.15079","article-title":"Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis","volume":"42","author":"John","year":"2022","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib44","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/s10620-021-07122-y","article-title":"Anti-mitochondrial antibody-negative primary biliary cholangitis is part of the same Spectrum of Classical primary biliary cholangitis","volume":"67","author":"Cancado","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"9039","key":"10.1016\/j.cld.2022.06.001_bib45","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.06.001_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2019.01.005","article-title":"Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker?","volume":"99","author":"Sun","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.001_bib47","doi-asserted-by":"crossref","first-page":"102578","DOI":"10.1016\/j.jaut.2020.102578","article-title":"Primary biliary cholangitis with normal alkaline phosphatase: a neglected clinical entity challenging current guidelines","volume":"116","author":"Terziroli Beretta-Piccoli","year":"2021","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/joim.13005","article-title":"Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up","volume":"287","author":"Zandanell","year":"2020","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib51","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","article-title":"Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis","volume":"66","author":"Natarajan","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on Graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib55","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0Placebo-controlled trial of Obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib56","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840040418","article-title":"Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women?","volume":"4","author":"Rubel","year":"1984","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2022.06.001_bib58","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study","volume":"50","author":"Myers","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2022.06.001_bib59","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2018.12.028","article-title":"Effects of age and sex of response to ursodeoxycholic acid and transplant-free survival in patients with primary biliary cholangitis","volume":"17","author":"Cheung","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib60","doi-asserted-by":"crossref","first-page":"262","DOI":"10.14309\/ajg.0000000000000512","article-title":"Ursodeoxycholic acid treatment Preferentially improves overall survival among African Americans with primary biliary cholangitis","volume":"115","author":"Gordon","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.001_bib61","article-title":"Ethnicity, disease severity and survival in Canadian patients with Primary Biliary Cholangitis","volume":"Feb 26","author":"Roberts","year":"2022","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2022.06.001_bib62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2022.06.001_bib65","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.13143","article-title":"Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up","volume":"36","author":"Gulamhusein","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.cld.2022.06.001_bib66","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/hep.22567","article-title":"Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls","volume":"48","author":"Invernizzi","year":"2008","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.cld.2022.06.001_bib67","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"issue":"23","key":"10.1016\/j.cld.2022.06.001_bib69","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1093\/hmg\/dds359","article-title":"Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants","volume":"21","author":"Juran","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib71","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2018.06.027","article-title":"Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis","volume":"69","author":"Probert","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2022.06.001_bib72","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0895-4356(00)00370-X","article-title":"Primary biliary cirrhosis among atomic bomb survivors in Nagasaki, Japan","volume":"54","author":"Ohba","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib73","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2011.03.031","article-title":"Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.06.001_bib74","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/liv.12434","article-title":"Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study","volume":"34","author":"Boonstra","year":"2014","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/nu14040878","article-title":"Vitamin D is associated with clinical outcomes in patients with primary biliary cholangitis","volume":"14","author":"Ebadi","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.cld.2022.06.001_bib76","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.32172","article-title":"E.\u00a0coli and the etiology of human PBC: antimitochondrial antibodies and spreading determinants","volume":"75","author":"Yang","year":"2022","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2022.06.001_bib77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000440754","article-title":"Geoepidemiology, genetic and environmental risk factors for PBC","volume":"33","author":"Zhang","year":"2015","journal-title":"Dig Dis"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib78","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1389201018666170224105600","article-title":"Clinical Applications of personalized medicine: a new paradigm and Challenge","volume":"18","author":"Di Sanzo","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"issue":"23","key":"10.1016\/j.cld.2022.06.001_bib79","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A\u00a0Placebo-controlled trial of Bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib80","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to Predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib81","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2022.06.001_bib82","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.14309\/ajg.0000000000001285","article-title":"A\u00a0Comparison of prognostic scores (Mayo, UK-PBC, and GLOBE) in primary biliary cholangitis","volume":"116","author":"Goet","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib83","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib84","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2018.11.008","article-title":"Epidemiology of primary biliary cholangitis in Italy: evidence from a real-world database","volume":"51","author":"Marzioni","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2022.06.001_bib85","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00038-020-01391-6","article-title":"Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia","volume":"65","author":"Drazilova","year":"2020","journal-title":"Int J Public Health"},{"issue":"1","key":"10.1016\/j.cld.2022.06.001_bib86","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","article-title":"Population-based epidemiology of primary biliary cirrhosis in South Korea","volume":"43","author":"Kim","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"1\u20132","key":"10.1016\/j.cld.2022.06.001_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3121\/cmr.2017.1351","article-title":"Incidence of primary biliary cholangitis in a rural Midwestern population","volume":"15","author":"Kanth","year":"2017","journal-title":"Clin Med Res"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib88","doi-asserted-by":"crossref","first-page":"E664","DOI":"10.9778\/cmajo.20180029","article-title":"Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study","volume":"6","author":"Yoshida","year":"2018","journal-title":"CMAJ Open"},{"issue":"4","key":"10.1016\/j.cld.2022.06.001_bib89","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/jgh.14924","article-title":"Increasing prevalence of primary biliary cholangitis in Victoria, Australia","volume":"35","author":"French","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.001_bib90","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:39Z","timestamp":1761069579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1089326122000393"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Epidemiology of Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}